🎓🔬 From Thesis to Transformation: Innovating for Cervical Cancer Screening in Kenya
During xLAB’s Founder Master’s research, she was determined to tackle a stubborn problem—late diagnosis of cervical cancer among Kenyan women. Cervical cancer, primarily caused by HPV 16 and 18, remains the second most common cancer in women in Kenya. Yet screening rates are painfully low, and the tests available are either too complex, costly, or […]
🎓🔬 From Thesis to Transformation: Innovating for Cervical Cancer Screening in Kenya Read More »

